SCHEMBL24589189

SCHEMBL24589189

COc1cc(C(C)Oc2c(I)cc(C(C)O)cc2OC)cc(I)c1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR3 P51677 1/20 0.38
▸ APP P05067 1/20 0.36
▸ TUBB4A P04350 3/20 0.35
▸ TUBB P07437 3/20 0.35
▸ TUBA3C P0DPH7 3/20 0.35
▸ TUBA1B P68363 3/20 0.35
▸ TUBA4A P68366 3/20 0.35
▸ TUBB4B P68371 3/20 0.35
▸ TUBB3 Q13509 3/20 0.35
▸ TUBB2A Q13885 3/20 0.35
▸ TUBB8 Q3ZCM7 3/20 0.35
▸ TUBA3E Q6PEY2 3/20 0.35
▸ TUBA1A Q71U36 3/20 0.35
▸ TUBA1C Q9BQE3 3/20 0.35
▸ TUBB6 Q9BUF5 3/20 0.35
▸ TUBB2B Q9BVA1 3/20 0.35
▸ TUBB1 Q9H4B7 3/20 0.35
▸ MAPT P10636 2/20 0.34
▸ RPS6KA3 P51812 1/20 0.33
▸ TRPV1 Q8NER1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24106144 0.87 APP (0.44) CCR3APPTUBB4ATUBBTUBA3C
SCHEMBL29695995 0.87 APP (0.44) CCR3APPTUBB4ATUBBTUBA3C
SCHEMBL22991685 0.85 TTR (0.35) MAPTLMNACYP3A4TPMT
SCHEMBL26740840 0.83 BACE1 (0.31) —
SCHEMBL24589185 0.79 APP (0.43) APPMAPTRPS6KA3TRPV1LMNA
SCHEMBL29695951 0.79 APP (0.43) APPMAPTRPS6KA3TRPV1LMNA
SCHEMBL24589109 0.79 APP (0.43) APPMAPTRPS6KA3TRPV1LMNA
SCHEMBL16271257 0.75 APP (0.45) APPMAPTRPS6KA3TRPV1LMNA
SCHEMBL24589219 0.75 APP (0.45) APPMAPTRPS6KA3TRPV1LMNA
SCHEMBL24106147 0.75 L3MBTL1 (0.39) CCR3TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348351-A1 COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-11-02 — — US disclosed
US-20230348351-A1 COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-11-02 — — US disclosed
WO-2022138670-A1 COMPOUND, POLYMER, COMPOSITION, FILM-FORMING COMPOSITION, PATTERN FORMATION METHOD, METHOD FOR FORMING INSULATING FILMS, AND COMPOUND PRODUCTION METHOD 三菱瓦斯化学株式会社 2022-06-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348351-A1 COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND PHOSPHO1, RER1, RIF1 CCR3 3778/4885APP 2177/4885TUBB4A 4124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback